Authorization Management

Did you know that authenticating via Availity gives you access to all the private information on our website? Login via Availity

Authorization Management

Last Updated: Tuesday, July 21, 2026

The preferred — and fastest — method to submit authorization requests and receive approvals is via Highmark’s provider portal, Availity Essentials.

For additional information and resources on submitting authorizations, go to the following page:

Highmark partners with vendors for the management of prior authorization for certain services.

  • wny
  • neny

The Laboratory Management Program is not applicable to New York.

  • wpa/ nepa
  • cpa/ sepa
  • de
  • wv

Highmark has partnered with eviCore to manage molecular/genomic, and non-molecular testing within the Laboratory Management Program. The Laboratory Management Program utilizes evidence-based policies, developed with trained experts, to ensure that the lab services provided to Highmark's members support clinically appropriate care and are medically necessary, in accordance with their benefit policy.

Highmark requires prior authorization for several molecular/genomic tests when performed in an outpatient setting for fully-insured Commercial, Affordable Care Act (ACA), and Medicare Advantage members.

These tests include:

  • Hereditary Cancer Screening
  • Carrier Screening Tests
  • Tumor Marker/Molecular Profiling
  • Hereditary Cardiac Disorders
  • Cardiovascular Disease and Thrombosis Risk Variant Testing
  • Pharmacogenomic Testing
  • Neurologic Disorders
  • Mitochondrial Disease Testing
  • Intellectual Disability/Developmental Disorders

 

Highmark requires claims review for several non-molecular tests when performed in an outpatient setting for fully insured Commercial, Affordable Care Act (ACA), and Medicare Advantage members. A prior authorization is not required for these tests.

These tests include: 

  • Cardiovascular Disease Risk Panels
  • Allergy Testing
  • Drug Testing
  • Celiac Disease
  • Vitamin D Testing
  • Thyroid Testing

 

Highmark has adopted eviCore’s molecular/genomic, and non-molecular testing policies. Policies and a complete list of impacted procedure codes are available here.

Learn More About the Laboratory Management Program

eviCore has a dedicated webpage for Highmark providers to conveniently access evidence-based clinical guidelines, the current CPT code list, important resources, and recent announcements. We encourage you to visit their site to ensure that you have the most current information:

Reference Materials

Highmark requires prior authorization for inpatient and outpatient musculoskeletal (MSK) and interventional pain management (IPM) procedures. New and continuing authorization requirements for inpatient and outpatient MSK and IPM services are managed directly by Highmark as of May 1, 2026.

These requirements apply to Highmark members enrolled in our fully insured Commercial, Medicare Advantage, and Affordable Care Act (ACA) plans, as well as members of select self-insured (Administrative Services Only) groups.

MSK procedures that require authorization include the following:

  • Large joint surgeries
  • Spine surgeries

Highmark has partnered with Evolent to manage medical and radiation oncology authorization requests for certain members as part of our oncology value-based care strategy. This collaboration aims to enhance clinical outcomes and streamline the authorization process.

Note: This information is for reference only and does not guarantee authorization or payment.

Evolent's clinical pathways do not replace third-party pathway tools. Practices may continue using established pathways in parallel with submitting oncology authorization requests.

Highmark members* included in Evolent’s authorization reviews are:

  • Commercial fully insured; Affordable Care Act (ACA); and Medicare Advantage members in Delaware, Pennsylvania, and West Virginia
  • Medicare Advantage members in New York
  • Pennsylvania Child Health Insurance Program (CHIP) members

 

*Radiation Oncology Authorization requests for Highmark Administrative Services Only (ASO) members will also continue to be requested through Availity but remain under eviCore review.

Requesting Authorization

Initial oncology authorization requests should be submitted through Availity.

Note: For Evolent-managed requests that go to review, providers must upload supporting clinical documentation directly to the Evolent CarePro portal.

 


If you have questions about Evolent programs, email providertraining@evolent.com.

  • wny
  • neny

The Radiation Therapy Authorization Program is not applicable to New York.

  • wpa/ nepa
  • cpa/ sepa
  • de
  • wv

In an effort to help ensure that the radiation oncology therapy services provided to our members are consistent with nationally recognized clinical guidelines, Highmark has contracted with eviCore healthcare to provide medical necessity review and authorization where applicable for select radiation oncology therapy services.

Resource